TG(18:2(9Z,12Z)/18:1(9Z)/18:3(9Z,12Z,15Z))[iso6]

Term ID

CHEBI:88881

Synonyms

(2R)-2-[(9Z)-octadec-9-enoyloxy]-3-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
1-Linoleoyl-2-oleoyl-3-a-linolenoyl-glycerol
1-Linoleoyl-2-oleoyl-3-alpha-linolenoyl-glycerol
TAG(18:2/18:1/18:3)
TAG(18:2n6/18:1n9/18:3n3)
TAG(18:2w6/18:1w9/18:3w3)
TAG(54:6)
TG(18:2/18:1/18:3)
TG(18:2n6/18:1n9/18:3n3)
TG(18:2w6/18:1w9/18:3w3)
TG(54:6)
Tracylglycerol(18:2/18:1/18:3)
Tracylglycerol(18:2n6/18:1n9/18:3n3)
Tracylglycerol(18:2w6/18:1w9/18:3w3)
Tracylglycerol(54:6)
Triacylglycerol
Triglyceride

(all 17)

Definition

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from TG(18:2(9Z,12Z)/18:1(9Z)/18:3(9Z,12Z,15Z))[iso6]

Phenotype where environments contain TG(18:2(9Z,12Z)/18:1(9Z)/18:3(9Z,12Z,15Z))[iso6]

Phenotype modified by environments containing TG(18:2(9Z,12Z)/18:1(9Z)/18:3(9Z,12Z,15Z))[iso6]

Phenotype affecting TG(18:2(9Z,12Z)/18:1(9Z)/18:3(9Z,12Z,15Z))[iso6]

Human Disease Model